Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
Highlights • FMP013 in ALFQ adjuvant induced a strong antibody and protective response in mice. • ALFQ was a more potent adjuvant than Montanide ISA 720. • ALFQ enhanced IgG2c, germinal center B-cells and antibody secreting cells. • ALFQ enhanced T-cell responses in a TH 1 biased manner. • FMP013 +...
Gespeichert in:
Veröffentlicht in: | Vaccine 2017-07, Vol.35 (31), p.3865-3874 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • FMP013 in ALFQ adjuvant induced a strong antibody and protective response in mice. • ALFQ was a more potent adjuvant than Montanide ISA 720. • ALFQ enhanced IgG2c, germinal center B-cells and antibody secreting cells. • ALFQ enhanced T-cell responses in a TH 1 biased manner. • FMP013 + ALFQ is under consideration for a human malaria vaccine trial. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2017.05.070 |